Under construction – not a live service
Sign in
Taking people in RussiaNo phase

Comparing Two Lymph Node Removal Methods for Left Colon Cancer

Compares two extents of lymph node removal during surgery for left-sided colon cancer.

Plain-language title generated from the registry record
Registry title: D2 vs D3 Lymph Node Dissection for Left Colon Cancer

Key facts

Where
Moscow, RussiaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT04364373, who can take part

Where in Russia

  • Clinic of coloproctology and minimally invasive surgeryMoscow, RussiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Russian Society of Colorectal Surgeons
Trial code
NCT04364373
Record updated
17 August 2026
Original description
The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.Read full original descriptionShow less

D2 vs D3 Lymph Node Dissection for Left Colon Cancer: Multicenter Randomize Control Trial (DILEMMA)

The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.

Inclusion: Agreement of the patient to participate in trial; Colon cancer (only adenocarcinoma ); The tumor located between the splenic flexure and rectosigmoid junction; cT3-Т4а,b; cN0-2; cM0; Tolerance of chemotherapy; ASA 1-3.

Exclusion: Previous radiotherapy or chemotherapy; Preoperative complications of the tumor (perforation and full bowel 3. obstruction); сТis - Т2, сТ4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder); Synchronous or metachronous tumors; Women during Pregnancy or breast feeding period.

ClinicalTrials.gov NCT04364373